Clinical trial ZEN003694-004
A Phase 2 Study of ZEN003694 in Combination with Talazoparib in Patients with Triple-Negative Breast Cancer
Cancers | |
---|---|
Organ | Breast |
Trial status | Trial closed |
Investigator | |
Trial type |
Interventional with experimental drug
|
Phase | Trial phase 2 |
Academic trial | Non |
Sponsor | Zenith Epigenetics Ltd. |
EudraCT Identifier | 2018-003906-26 |
ClinicalTrials.gov | https://clinicaltrials.gov/ct2/show/NCT03901469 |
Inclusion criteria | Triple-negative breast cancer |
Last update |